Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-01-02 @ 6:10 AM
Study NCT ID:
NCT05998993
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-21
First Post:
2023-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)
Sponsor:
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-28
First Submit QC Date:
None
Study First Post Date:
2023-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-16
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL